Audentes Therapeutics clinical trials
Acquired by Astellas Pharma Inc, Jan 15, 2020 · source ↗
The registry lists 2 studies whose lead sponsor is Audentes Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 18, 2022.
Before and after it joined Astellas Pharma Inc
- First submitted before Audentes Therapeutics became part of Astellas Pharma Inc
- 2
- First submitted after Audentes Therapeutics became part of Astellas Pharma Inc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Audentes Therapeutics2 studies
Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Astellas Pharma Inc studies →
- Gene Transfer Clinical Study in Crigler-Najjar SyndromeTerminatedNCT03223194Phase 1
Sponsor listed in the registry: Audentes Therapeutics · First submitted before Audentes Therapeutics became part of Astellas Pharma Inc
- Clinical Assessment Study in Crigler-Najjar SyndromeCompletedNCT03078881
Sponsor listed in the registry: Audentes Therapeutics · First submitted before Audentes Therapeutics became part of Astellas Pharma Inc